Prenetics(PRE.US)料明年COVID相關收入貢獻降至20%
基因及診斷檢測公司Prenetics Group宣佈,與新世界(00017.HK)執行副主席兼行政總裁鄭志剛旗下特殊目的收購公司(SPAC)Artisan Acquisition Corp.完成擬議業務合併,合併後A類普通股於納斯達克交易所上市,股份代號爲「PRE」。
Prenetics行政總裁兼聯合創辦人楊聖武透露,6月將推出兩款居家檢測產品,包括非入侵性大腸癌早期篩查檢查Circle ColoClear,
以及居家血液檢測Circle SnapShot,期望將檢測普及化,保守估計明年COVID-19相關產品的收入貢獻將由目前的75%降至約20%。
他又指,今年美國IPO市況較艱難,認爲成功上市已是公司發展重要裏程碑,現時帳上現金加上合併交易完成後所得資金,合計手頭現金達2.6億美元,正與數家公司洽談,包括視像診症、居家檢測技術、脫髮與陽痿治療以及輔助生育相關企業,目標今年內完成3宗併購交易。
楊聖武表示,Prenetics去年收入近2.76億美元,超出預期近35%,今年首季收入達9,200萬美元,相信可達到全年收入2.72億美元目標,並維持2025年收入達到6.4億美元及扭虧的目標。
問到在港發起SPAC的計劃,Artisan行政總裁鄭彥斌表示,近期港股市場及SPAC表現均未如理想,認爲若短期內情況持續,未必是最理想時機,但強調長遠支持香港市場發展,對在港設立SPAC保持開放態度。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.